Liu Bo, Liu Ruihe, Wang Lifeng
Department of Anesthesiology, Linyi People's Hospital Department of Anesthesiology, Women and Children's Health Care Hospital of Linyi, Shandong, China.
Medicine (Baltimore). 2017 Sep;96(37):e8031. doi: 10.1097/MD.0000000000008031.
Gabapentinoid drugs, which include gabapentin and pregabalin, play an established role in the management of neuropathic pain. However, whether preoperative administration of gabapentinoids has a beneficial role in controlling acute pain after spinal surgery is unknown. We performed a systematic review and meta-analysis of randomized controlled trials (RCTs) to determine the efficacy and safety of the preoperative use of gabapentinoids (gabapentin and pregabalin) for the treatment of acute postoperative pain following spinal surgery.
In March 2017, a systematic computer-based search was conducted in PubMed, EMBASE, Web of Science, Cochrane Library, and Google databases. RCTs comparing gabapentinoids (gabapentin and pregabalin) with placebo in patients undergoing spine surgery were retrieved. The primary endpoint was the visual analogue scale (VAS) score with rest or mobilization at 6, 12, 24, and 48 hours and cumulative morphine consumption at 24 and 48 hours. The secondary outcomes were complications of nausea, vomiting, sedation, dizziness, headache, urine retention, pruritus, and visual disturbances. After tests for publication bias and heterogeneity among studies were performed, data were aggregated for random-effects models when necessary.
Sixteen clinical studies (gabapentin group n = 8 and pregabalin group n = 8) were ultimately included in the meta-analysis. Gabapentinoids were associated with reduced pain scores at 6, 12, 24, and 48 hours. Similarly, gabapentinoids were associated with a reduction in cumulative morphine consumption at 24 and 48 hours. Furthermore, gabapentinoids can significantly reduce the occurrence of nausea, vomiting, and pruritus. There were no significant differences in the occurrence of sedation, dizziness, headache, visual disturbances, somnolence, or urine retention.
Preoperative use of gabapentinoids was able to reduce postoperative pain, total morphine consumption, and morphine-related complications following spine surgery. Further studies should determine the optimal dose and whether pregabalin is superior to gabapentin in controlling acute pain after spine surgery.
加巴喷丁类药物,包括加巴喷丁和普瑞巴林,在神经性疼痛的管理中发挥着既定作用。然而,术前给予加巴喷丁类药物在控制脊柱手术后的急性疼痛方面是否具有有益作用尚不清楚。我们进行了一项随机对照试验(RCT)的系统评价和荟萃分析,以确定术前使用加巴喷丁类药物(加巴喷丁和普瑞巴林)治疗脊柱手术后急性疼痛的疗效和安全性。
2017年3月,在PubMed、EMBASE、科学网、Cochrane图书馆和谷歌数据库中进行了基于计算机的系统检索。检索了比较加巴喷丁类药物(加巴喷丁和普瑞巴林)与安慰剂在脊柱手术患者中的RCT。主要终点是6、12、24和48小时静息或活动时的视觉模拟量表(VAS)评分以及24和48小时的累积吗啡消耗量。次要结局是恶心、呕吐、镇静、头晕、头痛、尿潴留、瘙痒和视觉障碍等并发症。在对研究中的发表偏倚和异质性进行检验后,必要时对随机效应模型的数据进行汇总。
最终有16项临床研究(加巴喷丁组n = 8,普瑞巴林组n = 8)纳入荟萃分析。加巴喷丁类药物与6、12、24和48小时时疼痛评分降低相关。同样,加巴喷丁类药物与24和48小时时累积吗啡消耗量减少相关。此外,加巴喷丁类药物可显著降低恶心、呕吐和瘙痒的发生率。在镇静、头晕、头痛、视觉障碍、嗜睡或尿潴留的发生率方面没有显著差异。
术前使用加巴喷丁类药物能够减轻脊柱手术后的疼痛、总吗啡消耗量以及与吗啡相关的并发症。进一步的研究应确定最佳剂量以及普瑞巴林在控制脊柱手术后急性疼痛方面是否优于加巴喷丁。